The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -2.99 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -4.57 — no flag raisedOK
- Earnings quality 93/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as Evolent Health, Inc. reports it. History and quarterly detail are in the app.
- Performance Suite$1.1B
- Specialty Technology and Services Suite$353.2M
- Administrative Services$226.7M
- Cases$169.0M
Leadership changes
From Evolent Health, Inc.'s own filings, the day they're filed.
- Jill Smith · chief executive officer · appointmenteff. 2025-12-02
- Diane Holder · Directors · departureeff. 2025-04-16
- Russell Glass · director · appointmenteff. 2024-02-14
Latest filings
- 8-K · Company announcement2026-06-04
- 8-K · Company announcement2026-05-07
- 10-Q · Quarterly report2026-05-07
- DEF 14A · Annual proxy (pay & governance)2026-04-24
- 10-K · Annual report2026-02-25
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about Evolent Health, Inc., every answer cited🔒
- The Intelligence Brief — added when Evolent Health, Inc.'s brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.